WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

WMT

120.7

+1.22%↑

COST

955.04

+1.19%↑

TGT

110.11

+1.35%↑

KR

61.37

-1.75%↓

DG.US

150.96

-1.35%↓

Search

Afya Ltd (Class A)

Открыт

СекторПотребительские товары
(защитный сектор)

14.57 -0.88

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

14.32

Макс.

14.75

Ключевые показатели

By Trading Economics

Доход

-13M

181M

Продажи

9.1M

929M

P/E

Средняя по отрасли

10.188

28.875

Дивидендная доходность

1.53

Рентабельность продаж

19.455

EBITDA

-28M

397M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+30.96% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

1.53%

3.67%

Следующий отчет о доходах

12 мар. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

64M

1.4B

Предыдущая цена открытия

15.45

Предыдущая цена закрытия

14.57

Новостные настроения

By Acuity

100%

0%

131 / 140 Рейтинг в Consumer defensive

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Afya Ltd (Class A) График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 янв. 2026 г., 22:41 UTC

Приобретения, слияния, поглощения

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 янв. 2026 г., 00:00 UTC

Отчет

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 янв. 2026 г., 23:47 UTC

Обсуждения рынка

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 янв. 2026 г., 23:44 UTC

Обсуждения рынка

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 янв. 2026 г., 23:39 UTC

Обсуждения рынка

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 янв. 2026 г., 23:32 UTC

Обсуждения рынка

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 янв. 2026 г., 22:56 UTC

Приобретения, слияния, поглощения

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 янв. 2026 г., 22:53 UTC

Приобретения, слияния, поглощения

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 янв. 2026 г., 22:17 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

14 янв. 2026 г., 22:17 UTC

Обсуждения рынка

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 янв. 2026 г., 22:09 UTC

Отчет

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 янв. 2026 г., 22:08 UTC

Отчет

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 янв. 2026 г., 22:08 UTC

Отчет

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 янв. 2026 г., 21:53 UTC

Приобретения, слияния, поглощения

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 янв. 2026 г., 21:53 UTC

Приобретения, слияния, поглощения

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 янв. 2026 г., 21:52 UTC

Приобретения, слияния, поглощения

WuXi XDC Announces Positive Profit Alert for 2025

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

Citigroup Acting as Financial Advisor to WuXi XDC

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 янв. 2026 г., 21:51 UTC

Приобретения, слияния, поглощения

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 янв. 2026 г., 21:50 UTC

Обсуждения рынка
Отчет

Financial Services Roundup: Market Talk

14 янв. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

14 янв. 2026 г., 21:49 UTC

Приобретения, слияния, поглощения

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 янв. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 янв. 2026 г., 21:48 UTC

Приобретения, слияния, поглощения

WuXi XDC Makes Cash Offer for BioDlink International

14 янв. 2026 г., 21:13 UTC

Обсуждения рынка

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 янв. 2026 г., 20:30 UTC

Обсуждения рынка
Отчет

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 янв. 2026 г., 20:13 UTC

Обсуждения рынка

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 янв. 2026 г., 20:08 UTC

Обсуждения рынка

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 янв. 2026 г., 19:33 UTC

Обсуждения рынка

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 янв. 2026 г., 19:06 UTC

Обсуждения рынка
Отчет

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Сравнение c конкурентами

Изменение цены

Afya Ltd (Class A) Прогноз

Целевая цена

By TipRanks

30.96% рост

Прогноз на 12 месяцев

Средняя 19.88 USD  30.96%

Максимум 22 USD

Минимум 17.5 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Afya Ltd (Class A) на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

4 ratings

2

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

18.968 / 19.56Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Strong Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat